Observational studyFrontiers in immunology2024

Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role.

Hongmei Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.